Onyx Pharmaceuticals, Inc. (ONXX) Misses Q1 EPS by 13c

Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) reported Q1 EPS of ($0.68), $0.13 worse than the analyst estimate of ($0.55). Revenue for the quarter came in at $72 million versus the consensus estimate of $69.82 million.

For earnings history and earnings-related data on Onyx Pharmaceuticals, Inc. (ONXX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
• Five Below (FIVE) Tops Q2 EPS by 35c, Beats on Revenue; Offers Q3 Revenue Guidance